Cortland Biomedical continues investments
Biomedical fabric manufacturer Cortland Biomedical said it remains on track to complete the transition to its new purpose-built manufacturing facility in the first quarter of its 2021 fiscal year.
The company has also expanded its textile manufacturing capabilities with the addition of knitting, weaving and high-carrier count braiding capacities, in addition to its existing braiding equipment.
For the full story, see the November 2020 edition of Medical Textiles.